News

Conducted across 19 countries, this large-scale observational study gathered data from 1,392 patients with CSU and 1,374 healthy controls.

A large Phase III trial has found that onradivir, a novel PB2 polymerase inhibitor, significantly shortens recovery time in adults with uncomplicated influenza A.

High-resolution ultrasound improves diagnosis of tendon and nerve injuries in forearm lacerations, supporting better trauma care outcomes.

Dapagliflozin shows promise for treating MASH, improving liver outcomes without worsening fibrosis in a major trial.

A 2023 global call to action by over 300 experts highlighted the need for clear, cross-specialty care pathways to support earlier identification and referral of people at risk.

A new analysis from the MONITOR-PsA study, presented at EULAR 2025, demonstrates that a pragmatic treat-to-target (T2T) approach in psoriatic arthritis leads to promising clinical outcomes over 48 weeks.

New findings identify distinct symptom clusters in young children with long COVID that differ from those observed in older children and adults.

A new study finds some non-alcoholic beers raise blood sugar and triglycerides, but pilsener appears metabolically safer.